The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDiaceutics Regulatory News (DXRX)

Share Price Information for Diaceutics (DXRX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 103.50
Bid: 102.00
Ask: 105.00
Change: 1.00 (0.98%)
Spread: 3.00 (2.941%)
Open: 103.00
High: 103.50
Low: 103.00
Prev. Close: 102.50
DXRX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notification of Major Holdings

21 Nov 2023 11:13

RNS Number : 1605U
Diaceutics PLC
21 November 2023

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00BJQTGV64

Issuer Name

DIACEUTICS PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

Danske Bank A/S

City of registered office (if applicable)

Copenhagen

Country of registered office (if applicable)

Denmark

4. Details of the shareholder

Name

City of registered office

Country of registered office

INVESTERINGSFORENINGEN DANSKE INVEST SELECT

INVESTERINGSFORENINGEN DANSKE INVEST

DANSKE INVEST MANAGEMENT/DANSKE INVEST LUXEMBOURG

DANSKE INVEST FUND MANAGEMENT LTD./DANSKE INVEST FINLAND

5. Date on which the threshold was crossed or reached

20-Nov-2023

6. Date on which Issuer notified

21-Nov-2023

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

4.578025

0.000000

4.578025

3867590

Position of previous notification (if applicable)

5.637134

0.000000

5.637134

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

GB00BJQTGV64

3867590

4.578025

Sub Total 8.A

3867590

4.578025%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

Sub Total 8.B2

9. Information in relation to the person subject to the notification obligation

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Danske Invest Luxembourg

1.209384

1.209384%

Danske Invest Finland

1.231354

1.231354%

Investeringsforeningen Danske Invest

1.358128

1.358128%

Investeringsforeningen Danske Invest Select

0.779159

0.779159%

10. In case of proxy voting

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional Information

12. Date of Completion

21-Nov-2023

13. Place Of Completion

DK - 1092 Copenhagen K

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
HOLFFLFLXFLFFBB
Date   Source Headline
7th Sep 20202:00 pmRNSPrice Monitoring Extension
7th Sep 202011:00 amRNSPrice Monitoring Extension
7th Sep 20207:00 amRNSHalf-year Report
27th Aug 20207:00 amRNSNotice of Results
22nd Jul 20207:00 amRNSNew contract win for DXRX platform
9th Jul 20207:00 amRNSHolding(s) in Company
8th Jul 20207:00 amRNSTrading update
6th Jul 20204:41 pmRNSSecond Price Monitoring Extn
6th Jul 20204:36 pmRNSPrice Monitoring Extension
3rd Jul 202010:43 amRNSHolding(s) in Company
3rd Jul 20207:00 amRNSIssue of Share Options
29th Jun 20202:55 pmRNSResult of General Meeting
19th Jun 20207:00 amRNSHolding(s) in Company
11th Jun 20202:00 pmRNSExercise of warrant
11th Jun 20207:00 amRNSPlacing of £20.5 million
19th May 20202:29 pmRNSResult of AGM
19th May 20207:00 amRNSAGM Statement
18th May 20207:00 amRNSDiagnostic network for precision medicine update
5th May 202011:22 amRNSDirector’s Shareholding - PCA Dealing
29th Apr 20207:00 amRNSCancer testing & diagnosis suffers sharp downturn
23rd Apr 20207:00 amRNSPosting of Annual Report and Notice of AGM
6th Apr 20207:00 amRNSIssue of Share Options
19th Mar 20207:00 amRNSBelfast investor presentation
17th Mar 20209:05 amRNSSecond Price Monitoring Extn
17th Mar 20209:00 amRNSPrice Monitoring Extension
16th Mar 202011:05 amRNSSecond Price Monitoring Extn
16th Mar 202011:00 amRNSPrice Monitoring Extension
16th Mar 20207:00 amRNSFinal Results
12th Mar 20202:24 pmRNSPrivate investor briefing
27th Feb 20207:00 amRNSNotice of Results
17th Feb 20207:00 amRNSBelfast investor presentation
6th Feb 20207:00 amRNSGrowth & Innovation Forum 2020
17th Jan 20202:53 pmRNSHolding(s) in Company
13th Jan 20209:05 amRNSSecond Price Monitoring Extn
13th Jan 20209:00 amRNSPrice Monitoring Extension
13th Jan 20207:00 amRNSYear-End Trading Update
25th Nov 20197:00 amRNSPresentation at AICon 2019
24th Oct 20197:00 amRNSPresentation at Big Data Belfast
21st Oct 20197:00 amRNSPharma Precision Medicine Readiness Report
10th Oct 20197:00 amRNSWorkshop presentation at EORTC
30th Sep 20198:01 amRNSPoster presentation at ESMO
23rd Sep 20197:00 amRNSDublin investor presentation
9th Sep 20197:00 amRNSHalf-year Report
8th Aug 20197:00 amRNSAppointment of Head of Global Data
8th Aug 20197:00 amRNSNotice of Results
8th Jul 20197:00 amRNSTrading update
17th Jun 20197:00 amRNSInvestment in data lake
28th May 20197:00 amRNSInvestor presentation
25th Mar 20194:29 pmRNSHolding(s) in Company
25th Mar 20197:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.